Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors

Abstract Artificial bone graft substitutes, such as Calcibon, are becoming increasingly interesting as they do not cause donor site morbidity which is an advantage compared to autologous bone grafts. The aim of this study was to evaluate the efficacy and potential complications associated with the u...

Full description

Saved in:
Bibliographic Details
Main Authors: Joerg Friesenbichler, Werner Maurer-Ertl, Marko Bergovec, Lukas A. Holzer, Kathrin Ogris, Lukas Leitner, Andreas Leithner
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
R
Q
Online Access:https://doaj.org/article/dced57d5ce424c1daf88dda5487ac74d
Tags: Add Tag
No Tags, Be the first to tag this record!